These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 17024760)

  • 1. Which drugs to prescribe.
    Ebell M
    Fam Pract Manag; 2006 Sep; 13(8):23-4; author reply 24. PubMed ID: 17024760
    [No Abstract]   [Full Text] [Related]  

  • 2. New drugs: how to decide which ones to prescribe.
    Mohler PJ
    Fam Pract Manag; 2006 Jun; 13(6):33-5. PubMed ID: 16813119
    [No Abstract]   [Full Text] [Related]  

  • 3. Safe and effective drug therapy in older adults.
    Hume AL
    Med Health R I; 2005 Jan; 88(1):15-7. PubMed ID: 15779550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Re-examining our approach to the approval and use of new drugs.
    Lee SK
    CMAJ; 2006 Jun; 174(13):1855. PubMed ID: 16785460
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacometrics at FDA: evolution and impact on decisions.
    Powell JR; Gobburu JV
    Clin Pharmacol Ther; 2007 Jul; 82(1):97-102. PubMed ID: 17538553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct-to-consumer advertising of prescription drugs: balancing benefits and risks, and a way forward.
    Kravitz RL; Bell RA
    Clin Pharmacol Ther; 2007 Oct; 82(4):360-2. PubMed ID: 17851573
    [No Abstract]   [Full Text] [Related]  

  • 7. New drugs. Should we prescribe them now or should we wait and see?
    Ladouceur R
    Can Fam Physician; 2001 Oct; 47():1947-8, 1955-7. PubMed ID: 11723584
    [No Abstract]   [Full Text] [Related]  

  • 8. [Development of a drug].
    Pujol MS; Woronoff-Lemsi MC
    Soins; 1998 Oct; (629):57-8. PubMed ID: 9934276
    [No Abstract]   [Full Text] [Related]  

  • 9. The risks of pharmacological therapy for insomnia (part 1): update for the clinical nurse specialist.
    O'Malley P
    Clin Nurse Spec; 2007; 21(4):188-90. PubMed ID: 17622806
    [No Abstract]   [Full Text] [Related]  

  • 10. Debate over credibility of natural health product claims.
    Kondro W
    CMAJ; 2005 Apr; 172(8):983. PubMed ID: 15824395
    [No Abstract]   [Full Text] [Related]  

  • 11. An overview of how drugs are designed and developed.
    Gallimore D
    Nurs Times; 2006 Nov 21-27; 102(47):30-1. PubMed ID: 17153043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic studies in pregnant women.
    Anger GJ; Piquette-Miller M
    Clin Pharmacol Ther; 2008 Jan; 83(1):184-7. PubMed ID: 17882157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cause and effect? Assessing postmarketing safety studies as evidence of causation in products liability cases.
    Shea LL; Hanson A; Guglielmetti TM; Levy K
    Food Drug Law J; 2007; 62(3):445-72. PubMed ID: 17915388
    [No Abstract]   [Full Text] [Related]  

  • 14. [Drug surveillance in patients of advanced-age].
    Bol Oficina Sanit Panam; 1984 Apr; 96(4):342-52. PubMed ID: 6233994
    [No Abstract]   [Full Text] [Related]  

  • 15. Cardiovascular safety of drugs not intended for cardiovascular use: need for a new conceptual basis for assessment and approval.
    Borer JS; Pouleur H; Abadie E; Follath F; Wittes J; Pfeffer MA; Pitt B; Zannad F
    Eur Heart J; 2007 Aug; 28(15):1904-9. PubMed ID: 17615083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Confidentiality laws and secrecy in medical research: improving public access to data on drug safety.
    Kesselheim AS; Mello MM
    Health Aff (Millwood); 2007; 26(2):483-91. PubMed ID: 17339677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Post-marketing strategies for medicines.
    Breckenridge A
    Clin Pharmacol Ther; 2008 Jan; 83(1):24-5; discussion 25. PubMed ID: 18043682
    [No Abstract]   [Full Text] [Related]  

  • 18. The new drug evaluation process: risk benefit ratio.
    Somberg JC
    Am J Ther; 2005; 12(3):199-200. PubMed ID: 15891261
    [No Abstract]   [Full Text] [Related]  

  • 19. Biologics for inflammatory bowel disease: drug approval and monitoring in the United States.
    Tremaine WJ
    Gastroenterol Clin North Am; 2006 Dec; 35(4):735-41. PubMed ID: 17129810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Developing a paradigm of drug innovation: an evaluation algorithm.
    Caprino L; Russo P
    Drug Discov Today; 2006 Nov; 11(21-22):999-1006. PubMed ID: 17055409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.